SUMMARY At the onset of Still's disease (systemic-onset juvenile arthritis) in a 12-year-old girl, serological evidence of Coxsackie B virus infection was found. Two weeks later she developed a haemophagocytic syndrome which was then treated with cytotoxic therapy. Her arthritis is still active six years later.
In 1939 Scott and Robb-Smith described histiocytic medullary reticulosis (HMR): 'Fever, wasting, and generalised lymphadenopathy are associated with splenic and hepatic enlargement, and in the final stages jaundice, purpura, and anaemia with proound leucopenia may occur. Postmortem examination shows a systematised hyperplasia of histiocytes actively engaged in phagocytosis of erythrocytes."
Until recently the disease was accepted as a malignant histiocytosis.2 However, in some cases the histiocyte morphology appeared normal,3 and other patients had a self-limiting disease.4 5 After these reports of self-limiting haemophagocytic disorders Risdall et al. (1979) She experienced abdominal pain, possibly due to vincristine, and subsequently had three short courses of vinblastine and prednisone. After this bone marrow aspiration cytology and serum muramidase were normal. Treatment was changed to the CHOP protocol (cyclophosphamide, adriamycin, vincristine, and prednisone), 14 and she received seven courses over the next seven months. During chemotherapy she had occasional joint pains and a transient erythematous rash. Five months after stopping chemotherapy she developed a nonbacterial meningitis which coincided with a local epidemic of ECHO virus. Viral cultures were negative. Coxsackie antibody titres were repeated and the B4 titre had fallen to 32 and B2 to less than 8 (Table 1) .
During chemotherapy over 10 months her arthritis remained quiescent apart from occasional arthralgia. However, she developed more severe pain, morning stiffness, and evening pyrexia, with synovitis in feet, knees, and wrists and a macular rash on the trunk three months after the last CHOP course. She was treated with aspirin, indomethacin, and local steroids. Systemic steroids were required for one year. A course of gold injections was terminated when significant eosinophilia developed. At various times she has received naproxen, sulindac, and diflunisal.
In 1984, she continues to have moderately active synovitis in her hands and feet and x-rays show erosive changes in the following joints: proximal interphalangeal joints of both index and little fingers; distal interphalangeal joints of left middle, right index, middle, and ring fingers; the carpometacarpal joints of both wrists; and the tarsal and tarsometatarsal joints of both feet. She is otherwise well. Her periods began at age 14 and are normal.
The following tests are now normal: haematology apart from ESR, liver function tests and clotting 
Discussion
The illness at the time of our patient's second hospital admission was consistent with severe systemic Still's disease but with an unusually sudden onset of pancytopenia associated with fever, hepatomegaly, and jaundice. She had been on no drugs that one could indict in this regard. The presence of immature and mature histiocytes with phagocytosis in the bone marrow supported a diagnosis of HMR and explained the haematological findings. A leucocytosis is common in Still's disease and pancytopenia is rare in the absence of drug toxicity, though erythroid aplasia has been reported. ' 
